Research

Mixed

The kidney benefits of semaglutide are largely mediated by weight loss, although direct GLP-1 receptor effects on the kidney may also contribute.

While semaglutide has direct kidney-protective properties, most of its benefit comes from the weight loss it induces. Therefore, maintaining weight loss is crucial for sustaining kidney protection.

GoodQualifiesMEDIUM confidence
However, a mediation analysis suggested that 81% (95% CI 41.30, 120) of the change in eGFR was attributable to change in body weight with considerable imprecision in the estimate.
Helen M. Colhoun et al. · Nature Medicine · 2024

Why this rating

Mediation analysis was exploratory and had considerable imprecision.

Source

Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial

Helen M. Colhoun et al. · Nature Medicine · 2024

DOI 10.1038/s41591-024-03015-5

rct · n=17604Cited 193×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →